About THERASET®
Theraset positions itself as a reliable, PLLA-based collagen stimulator with impressive duration and natural volumizing properties. Developed by WIZCHEM Co., Ltd., Theraset leverages FDA-recognized materials and CE certification to ensure safety and quality. Designed for practitioners seeking long-term facial rejuvenation solutions, Theraset integrates seamlessly into aesthetic regimes focused on progressive, structural skin rebuilding and contour correction. Its clinical profile and techniques make it a competitive option in the regenerative filler market.
Theraset®
Theraset is a PLLA-based “collagenesis” filler designed to naturally restore facial volume and improve skin texture by stimulating endogenous collagen production. Each vial contains 365 mg of biodegradable PLLA microspheres in a sterile suspension. After subcutaneous injection, Theraset initiates a controlled inflammatory and fibroblast response, triggering collagen formation. The result is gradual volumetry—visible in 4–5 weeks—with effects lasting up to 24–25 months. Theraset is indicated for correction of deep wrinkles, volume loss, lipoatrophy, and contour deformities, and it is also used for facial rejuvenation and structural enhancement.
Key Features:
• Active Ingredient: Biodegradable PLLA microspheres (365 mg per vial).
• Certifications: CE marked; PLLA confirmed by FDA as a medical-grade material.
• Clinical Benefits: Gradual collagen stimulation, natural volume restoration visible after ~4–5 weeks, with effects lasting up to 25 months.
• Application Areas: Deep wrinkles, nasolabial folds, marionette lines, facial lipoatrophy, volume loss, and contour deformities.
• Injection Format: Powder vial requiring reconstitution; recommended use with ≥ 23G needle, agitation during treatment, gentle post-injection massage.
Theraset® Volume
Theraset Volume is a specialized PLLA-based injectable designed to provide enhanced volumizing effects through deeper collagen stimulation. Also formulated with 365 mg of biodegradable poly L lactic acid per vial, Theraset Volume is tailored for more significant structural correction in areas of pronounced facial atrophy or volume loss. Upon reconstitution and administration, it activates the skin's natural regenerative cascade, triggering gradual yet substantial neocollagenesis. The treatment visibly restores contour and elasticity over a period of several weeks, with results sustained for up to 24–25 months. Theraset Volume is ideal for practitioners seeking a high-efficacy biostimulator for long-term facial volume enhancement in demanding clinical indications.
Key Features:
• Active Ingredient: Poly L Lactic Acid microspheres (365 mg per vial).
• Certifications: CE certified; high-purity PLLA recognized for medical use.
• Clinical Benefits: Robust collagen induction, progressive volumetric correction, long-lasting structural support.
• Application Areas: Mid-face and temple hollowing, pronounced volume loss, structural augmentation of facial contours.
• Injection Format: Requires proper reconstitution; recommended for subcutaneous or supraperiosteal injection with post-treatment massage to ensure even dispersion.
About WIZCHEM Co., Ltd.
WIZCHEM Co., Ltd., based in South Korea, specializes in advanced aesthetic and dermal medical products. Their flagship range, the Theraset fillers, harness proven Poly L Lactic Acid (PLLA) technology. WIZCHEM exports globally and maintains CE certification, aligning with international medical device standards. Its R&D is focused on collagen-stimulating injectables for long-lasting, skin-reviving treatments.